Organovo控股 ONVO 深 滬
已收盤 04-23 16:00:00 美东时间
2.04
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 2.04
- 總市值 363.79万
- 52周最高 21.96
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 1.56
- 委 比 0.00%
- 總股本 178.33万
- 歷史最高 3276.00
- 量 比 0
- 振 幅 0.00%
- 歷史最低 3.0372
- 每 手 1
- 風險率 2.47%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多港股周报丨疯狂扫货！北水年内净流入港股超万亿港元；创新药概念狂飙，三生制药周涨超22%
疯狂扫货！北水年内净流入港股超万亿港元；创新药概念狂飙，三生制药周涨超22%，恒瑞医药周涨超13%；估值仍具吸引力！瑞银看多中国市场AI投资机会>>
2025-09-06 15:18
Organovo Holdings Announces Transition to VivoSim Labs
An update from Organovo Holdings ( ($ONVO) ) is now available. On April 23, 202...
2025-04-23 20:29
Organovo reports $11.3M cash balance in FY24
Organovo (NASDAQ:ONVO) said on Wednesday that its preliminary cash and cash equivalents balance was about $11.3M as of the end of the fiscal year on March 31, 2025. Organovo’s preliminary net cash uti...
2025-04-02 20:51
Organovo Holdings Expects to Meet Nasdaq Listing Requirements
Organovo Holdings ( ($ONVO) ) has issued an announcement. Organovo Holdings, In...
2025-04-02 20:27
Organovo Holdings Completes FXR Program Sale to Eli Lilly
Organovo Holdings ( ($ONVO) ) has shared an update. On March 25, 2025, Organovo...
2025-03-26 20:28
Organovo Announces 1-for-12 Reverse Stock Split
An update from Organovo Holdings ( ($ONVO) ) is now available. On March 19, 202...
2025-03-19 20:27
Organovo announces reverse stock split; shares fall
Organovo Holdings (NASDAQ:ONVO) said on Wednesday that it will effect a 1-for-12 reverse stock split of its issued and outstanding common stock that will become effective on Thursday, March 20, 2025. ...
2025-03-19 20:14
Organovo shares are trading higher after the company announced issuance of additional shares.
Organovo shares are trading higher after the company announced issuance of addi...
2025-03-06 21:46
礼来(LLY.US)收购Organovo旗下FXR项目及主打疗法FXR314 用于治疗溃疡性结肠炎
目前，Organovo已获得美国FDA的临床试验许可，正在进行其主打疗法FXR314用于治疗溃疡性结肠炎（UC）的2期试验。
2025-02-26 07:56
Why Organovo (ONVO) Stock Is Skyrocketing
Organovo shares are trading higher by 246% Tuesday morning. The company announced that Eli Lilly is set to acquire its FXR program, including FXR314.
2025-02-25 22:50
